Literature DB >> 28918193

Psychedelic pleasures: An affective understanding of the joys of tripping.

Frederik Bøhling1.   

Abstract

BACKGROUND: This paper considers the pleasures of psychedelic drugs and proposes a Deleuzian understanding of drugged pleasures as affects. In spite of a large body of work on psychedelics, not least on their therapeutic potentials, the literature is almost completely devoid of discussions of the recreational practices and pleasures of entheogenic drugs. Yet, most people do not use psychedelics because of their curative powers, but because they are fun and enjoyable ways to alter the experience of reality.
METHODS: In the analytical part of the paper, I examine 100 trip reports from an internet forum in order to explore the pleasures of tripping.
RESULTS: The analyses map out how drugs such as LSD and mushrooms - in combination with contextual factors such as other people, music and nature - give rise to a set of affective modifications of the drug user's capacities to feel, sense and act.
CONCLUSION: In conclusion it is argued that taking seriously the large group of recreational users of hallucinogens is important not only because it broadens our understanding of how entheogenic drugs work in different bodies and settings, but also because it may enable a more productive and harm reductive transmission of knowledge between the scientific and recreational psychedelic communities.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affect theory; Alcohol and other drugs; Deleuze; Pleasure; Psychedelic drugs; Trip reports

Mesh:

Substances:

Year:  2017        PMID: 28918193     DOI: 10.1016/j.drugpo.2017.07.017

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  4 in total

Review 1.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

Review 2.  Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature.

Authors:  Tasha L Golden; Susan Magsamen; Clara C Sandu; Shuyang Lin; Grace Marie Roebuck; Kathy M Shi; Frederick S Barrett
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Amphetamine and the Smart Drug 3,4-Methylenedioxypyrovalerone (MDPV) Induce Generalization of Fear Memory in Rats.

Authors:  Paola Colucci; Giulia Federica Mancini; Alessia Santori; Clemens Zwergel; Antonello Mai; Viviana Trezza; Benno Roozendaal; Patrizia Campolongo
Journal:  Front Mol Neurosci       Date:  2019-11-29       Impact factor: 5.639

4.  Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience.

Authors:  Madelene Palmer; Olivia M Maynard
Journal:  Harm Reduct J       Date:  2022-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.